Home

Kevin Koch, President and CEO: Edgewise Therapeutics EWTX Sell · Filed 25/02/07

Trade details

Type
Insider sale
Amount
$259,339.08
Shares · price
8,636 sh · $30.03 a share
Held after
14,478 sh
Trade date
25/02/05
Filed
25/02/07
Days to filing
2 days

Sold 37.4% of holdings

Share of holding sold
37.4%

Edgewise Therapeutics trades, last 26 weeks

What else happened in Edgewise Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/06~25/03/07

Kevin Koch's recent trades

  • Kevin Koch

    SellEdgewise Therapeutics

    $106.7K

    Filed 25/08/14

  • Kevin Koch

    SellEdgewise Therapeutics

    $70.3K

    Filed 25/05/07

  • Kevin Koch

    Sell10b5-1 planEdgewise Therapeutics

    $3,000

    Filed 25/03/11

  • Kevin Koch

    Sell10b5-1 planEdgewise Therapeutics

    $28K

    Filed 25/02/07

  • Koch Kevin

    Planned sale10b5-1 planEdgewise Therapeutics

    $1.5M

    Filed 25/02/05

Kevin Koch, CEO — sold $259.3K of Edgewise Therapeutics EWTX · 37.4% of holdings · 10b5-1 plan | Whalegun